Nyctanthes arbor-tristis Improves Blood Pressure via Endothelial Pathway: In Silico, Ex Vivo, and In Vivo Evidence
Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds respons...
Saved in:
| Published in | Cell biochemistry and biophysics Vol. 83; no. 2; pp. 1861 - 1877 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York
Springer US
01.06.2025
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1559-0283 1085-9195 1559-0283 |
| DOI | 10.1007/s12013-024-01594-1 |
Cover
| Abstract | Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs.
Nyctanthes arbor-tristis
has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds responsible for its antihypertensive effects remain elusive. Therefore, this study aims to elucidate the antihypertensive activity of
N. arbor-tristis
leaves in rats and explore associated mechanism through in silico, in vitro, ex vivo, and in vivo studies. The methanolic extract of
N. arbor-tristis
leaves (MENAT) was fractionated and subjected to qualitative and quantitative phytochemical screening, including total phenolic content (Folin-Ciocalteu method), total flavonoid content (Aluminum chloride method), and total alkaloid content (spectrometric method). Antioxidant studies were conducted using DPPH, FRAP, and H
2
O
2
assays. The most promising fraction (WNAT) was analyzed using LC-MS, and the identified compounds were used for molecular docking studies against cGMP and eNOS. Further, aortic ring assays were conducted to assess ex vivo vasorelaxant activity (rat aortic strip assay) and the underlying mechanisms of WNAT. Later, in vivo studies using a DOCA-salt-induced hypertension model in Wistar rats, along with molecular analyses (RT-PCR), were performed to validate the antihypertensive claims of
N. arbor-tristis
. In vitro studies demonstrated that the water extract of
N. arbor-tristis
leaves (WNAT) exhibited strong antioxidant activity and contained key phytochemicals. LC-MS analysis revealed the presence of 19 major compounds, including betulinic acid and arbortristosides. Molecular docking studies indicated that arborside C exhibited a strong affinity for both eNOS and cGMP. Ex vivo studies involving rat aortic strips showed that WNAT induced vasodilatory activity, which is associated with parasympathetic and nitric oxide-related pathways. In vivo experiments further supported WNAT’s antihypertensive properties through improvements via amelioration of rat blood pressure and histological features, biochemical markers, morphometric parameters, and gene expression in hypertensive rats. In conclusion, WNAT effectively lowers blood pressure through modulation of the endothelial pathway and warrants further studies to attain its clinical utility in hypertensive subjects.
Graphical Abstract
Highlights
Nyctanthes arbor-tristis
has notable antihypertensive properties.
Arborside C exhibits impressive affinity with cGMP and NO.
The water fraction of MENAT (WNAT) modulates the levels of the Soluble guanylyl cyclase (sGC) gene in the cardiac tissues of DOCA-salt-induced hypertensive rats. |
|---|---|
| AbstractList | Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds responsible for its antihypertensive effects remain elusive. Therefore, this study aims to elucidate the antihypertensive activity of N. arbor-tristis leaves in rats and explore associated mechanism through in silico, in vitro, ex vivo, and in vivo studies. The methanolic extract of N. arbor-tristis leaves (MENAT) was fractionated and subjected to qualitative and quantitative phytochemical screening, including total phenolic content (Folin-Ciocalteu method), total flavonoid content (Aluminum chloride method), and total alkaloid content (spectrometric method). Antioxidant studies were conducted using DPPH, FRAP, and H2O2 assays. The most promising fraction (WNAT) was analyzed using LC-MS, and the identified compounds were used for molecular docking studies against cGMP and eNOS. Further, aortic ring assays were conducted to assess ex vivo vasorelaxant activity (rat aortic strip assay) and the underlying mechanisms of WNAT. Later, in vivo studies using a DOCA-salt-induced hypertension model in Wistar rats, along with molecular analyses (RT-PCR), were performed to validate the antihypertensive claims of N. arbor-tristis. In vitro studies demonstrated that the water extract of N. arbor-tristis leaves (WNAT) exhibited strong antioxidant activity and contained key phytochemicals. LC-MS analysis revealed the presence of 19 major compounds, including betulinic acid and arbortristosides. Molecular docking studies indicated that arborside C exhibited a strong affinity for both eNOS and cGMP. Ex vivo studies involving rat aortic strips showed that WNAT induced vasodilatory activity, which is associated with parasympathetic and nitric oxide-related pathways. In vivo experiments further supported WNAT's antihypertensive properties through improvements via amelioration of rat blood pressure and histological features, biochemical markers, morphometric parameters, and gene expression in hypertensive rats. In conclusion, WNAT effectively lowers blood pressure through modulation of the endothelial pathway and warrants further studies to attain its clinical utility in hypertensive subjects.Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds responsible for its antihypertensive effects remain elusive. Therefore, this study aims to elucidate the antihypertensive activity of N. arbor-tristis leaves in rats and explore associated mechanism through in silico, in vitro, ex vivo, and in vivo studies. The methanolic extract of N. arbor-tristis leaves (MENAT) was fractionated and subjected to qualitative and quantitative phytochemical screening, including total phenolic content (Folin-Ciocalteu method), total flavonoid content (Aluminum chloride method), and total alkaloid content (spectrometric method). Antioxidant studies were conducted using DPPH, FRAP, and H2O2 assays. The most promising fraction (WNAT) was analyzed using LC-MS, and the identified compounds were used for molecular docking studies against cGMP and eNOS. Further, aortic ring assays were conducted to assess ex vivo vasorelaxant activity (rat aortic strip assay) and the underlying mechanisms of WNAT. Later, in vivo studies using a DOCA-salt-induced hypertension model in Wistar rats, along with molecular analyses (RT-PCR), were performed to validate the antihypertensive claims of N. arbor-tristis. In vitro studies demonstrated that the water extract of N. arbor-tristis leaves (WNAT) exhibited strong antioxidant activity and contained key phytochemicals. LC-MS analysis revealed the presence of 19 major compounds, including betulinic acid and arbortristosides. Molecular docking studies indicated that arborside C exhibited a strong affinity for both eNOS and cGMP. Ex vivo studies involving rat aortic strips showed that WNAT induced vasodilatory activity, which is associated with parasympathetic and nitric oxide-related pathways. In vivo experiments further supported WNAT's antihypertensive properties through improvements via amelioration of rat blood pressure and histological features, biochemical markers, morphometric parameters, and gene expression in hypertensive rats. In conclusion, WNAT effectively lowers blood pressure through modulation of the endothelial pathway and warrants further studies to attain its clinical utility in hypertensive subjects. Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds responsible for its antihypertensive effects remain elusive. Therefore, this study aims to elucidate the antihypertensive activity of N. arbor-tristis leaves in rats and explore associated mechanism through in silico, in vitro, ex vivo, and in vivo studies. The methanolic extract of N. arbor-tristis leaves (MENAT) was fractionated and subjected to qualitative and quantitative phytochemical screening, including total phenolic content (Folin-Ciocalteu method), total flavonoid content (Aluminum chloride method), and total alkaloid content (spectrometric method). Antioxidant studies were conducted using DPPH, FRAP, and H 2 O 2 assays. The most promising fraction (WNAT) was analyzed using LC-MS, and the identified compounds were used for molecular docking studies against cGMP and eNOS. Further, aortic ring assays were conducted to assess ex vivo vasorelaxant activity (rat aortic strip assay) and the underlying mechanisms of WNAT. Later, in vivo studies using a DOCA-salt-induced hypertension model in Wistar rats, along with molecular analyses (RT-PCR), were performed to validate the antihypertensive claims of N. arbor-tristis . In vitro studies demonstrated that the water extract of N. arbor-tristis leaves (WNAT) exhibited strong antioxidant activity and contained key phytochemicals. LC-MS analysis revealed the presence of 19 major compounds, including betulinic acid and arbortristosides. Molecular docking studies indicated that arborside C exhibited a strong affinity for both eNOS and cGMP. Ex vivo studies involving rat aortic strips showed that WNAT induced vasodilatory activity, which is associated with parasympathetic and nitric oxide-related pathways. In vivo experiments further supported WNAT’s antihypertensive properties through improvements via amelioration of rat blood pressure and histological features, biochemical markers, morphometric parameters, and gene expression in hypertensive rats. In conclusion, WNAT effectively lowers blood pressure through modulation of the endothelial pathway and warrants further studies to attain its clinical utility in hypertensive subjects. Graphical Abstract Highlights Nyctanthes arbor-tristis has notable antihypertensive properties. Arborside C exhibits impressive affinity with cGMP and NO. The water fraction of MENAT (WNAT) modulates the levels of the Soluble guanylyl cyclase (sGC) gene in the cardiac tissues of DOCA-salt-induced hypertensive rats. Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds responsible for its antihypertensive effects remain elusive. Therefore, this study aims to elucidate the antihypertensive activity of N. arbor-tristis leaves in rats and explore associated mechanism through in silico, in vitro, ex vivo, and in vivo studies. The methanolic extract of N. arbor-tristis leaves (MENAT) was fractionated and subjected to qualitative and quantitative phytochemical screening, including total phenolic content (Folin-Ciocalteu method), total flavonoid content (Aluminum chloride method), and total alkaloid content (spectrometric method). Antioxidant studies were conducted using DPPH, FRAP, and H O assays. The most promising fraction (WNAT) was analyzed using LC-MS, and the identified compounds were used for molecular docking studies against cGMP and eNOS. Further, aortic ring assays were conducted to assess ex vivo vasorelaxant activity (rat aortic strip assay) and the underlying mechanisms of WNAT. Later, in vivo studies using a DOCA-salt-induced hypertension model in Wistar rats, along with molecular analyses (RT-PCR), were performed to validate the antihypertensive claims of N. arbor-tristis. In vitro studies demonstrated that the water extract of N. arbor-tristis leaves (WNAT) exhibited strong antioxidant activity and contained key phytochemicals. LC-MS analysis revealed the presence of 19 major compounds, including betulinic acid and arbortristosides. Molecular docking studies indicated that arborside C exhibited a strong affinity for both eNOS and cGMP. Ex vivo studies involving rat aortic strips showed that WNAT induced vasodilatory activity, which is associated with parasympathetic and nitric oxide-related pathways. In vivo experiments further supported WNAT's antihypertensive properties through improvements via amelioration of rat blood pressure and histological features, biochemical markers, morphometric parameters, and gene expression in hypertensive rats. In conclusion, WNAT effectively lowers blood pressure through modulation of the endothelial pathway and warrants further studies to attain its clinical utility in hypertensive subjects. Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis has garnered increasing attention for its perceived efficacy and safety, though its mechanisms of action and the bioactive compounds responsible for its antihypertensive effects remain elusive. Therefore, this study aims to elucidate the antihypertensive activity of N. arbor-tristis leaves in rats and explore associated mechanism through in silico, in vitro, ex vivo, and in vivo studies. The methanolic extract of N. arbor-tristis leaves (MENAT) was fractionated and subjected to qualitative and quantitative phytochemical screening, including total phenolic content (Folin-Ciocalteu method), total flavonoid content (Aluminum chloride method), and total alkaloid content (spectrometric method). Antioxidant studies were conducted using DPPH, FRAP, and H2O2 assays. The most promising fraction (WNAT) was analyzed using LC-MS, and the identified compounds were used for molecular docking studies against cGMP and eNOS. Further, aortic ring assays were conducted to assess ex vivo vasorelaxant activity (rat aortic strip assay) and the underlying mechanisms of WNAT. Later, in vivo studies using a DOCA-salt-induced hypertension model in Wistar rats, along with molecular analyses (RT-PCR), were performed to validate the antihypertensive claims of N. arbor-tristis. In vitro studies demonstrated that the water extract of N. arbor-tristis leaves (WNAT) exhibited strong antioxidant activity and contained key phytochemicals. LC-MS analysis revealed the presence of 19 major compounds, including betulinic acid and arbortristosides. Molecular docking studies indicated that arborside C exhibited a strong affinity for both eNOS and cGMP. Ex vivo studies involving rat aortic strips showed that WNAT induced vasodilatory activity, which is associated with parasympathetic and nitric oxide-related pathways. In vivo experiments further supported WNAT’s antihypertensive properties through improvements via amelioration of rat blood pressure and histological features, biochemical markers, morphometric parameters, and gene expression in hypertensive rats. In conclusion, WNAT effectively lowers blood pressure through modulation of the endothelial pathway and warrants further studies to attain its clinical utility in hypertensive subjects.HighlightsNyctanthes arbor-tristis has notable antihypertensive properties.Arborside C exhibits impressive affinity with cGMP and NO.The water fraction of MENAT (WNAT) modulates the levels of the Soluble guanylyl cyclase (sGC) gene in the cardiac tissues of DOCA-salt-induced hypertensive rats. |
| Author | Paliwal, Sarvesh Verma, Kanika Jain, Smita Paliwal, Vartika Sharma, Swapnil Chaturvedi, Akanksha Sharma, Pragya |
| Author_xml | – sequence: 1 givenname: Akanksha surname: Chaturvedi fullname: Chaturvedi, Akanksha organization: Department of Pharmacy, Banasthali Vidyapith, Department of Pharmacology, All India Institute of Medical Sciences – sequence: 2 givenname: Kanika surname: Verma fullname: Verma, Kanika organization: Department of Internal Medicine, Division of Cardiology, LSU Health Sciences Center – sequence: 3 givenname: Smita surname: Jain fullname: Jain, Smita organization: Department of Pharmacy, Central University of Rajasthan – sequence: 4 givenname: Pragya surname: Sharma fullname: Sharma, Pragya organization: Department of Pharmacy, Banasthali Vidyapith – sequence: 5 givenname: Vartika surname: Paliwal fullname: Paliwal, Vartika organization: Department of Pharmacy, Banasthali Vidyapith – sequence: 6 givenname: Sarvesh surname: Paliwal fullname: Paliwal, Sarvesh organization: Department of Pharmacy, Banasthali Vidyapith – sequence: 7 givenname: Swapnil orcidid: 0000-0003-2639-7096 surname: Sharma fullname: Sharma, Swapnil email: skspharmacology@gmail.com organization: Department of Pharmacy, Banasthali Vidyapith |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39476265$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUlvFDEQhS2UiCzwBzggS1w40ODdbW4QDclIEYlEwtVyeyGOeuxgdw_Mv48nExZx4OTy0_eq7HpHYC_l5AF4gdFbjJB8VzFBmHaIsA5hrliHn4BDzLlqUk_3_qoPwFGttwgRghh7Cg6oYlIQwQ9B-byxk0nTja_QlCGXbiqxTrHC5equ5HWTP445O3hZfK1z8XAdDVwkl5tljGaEl2a6-WE27-EywS9xjDa_gYuf8Gtct8Ikt9W3F7hYR-eT9c_AfjBj9c8fz2Nw_WlxdXLWnV-cLk8-nHeWEjF1vbRcBOkGwygKgQspDReCBYmGQL1iarCEmx77YGTfB4aVtB475Dh2VnF6DF7v-rZ_fJ99nfQqVuvH0SSf56opJkRQzpRq6Kt_0Ns8l9RepylBgjBCJW3Uy0dqHlbe6bsSV6Zs9K9tNoDsAFtyrcWH3whGehuZ3kWmW2T6ITKNm4nuTLXB6Zsvf2b_x3UP-imXeA |
| Cites_doi | 10.25259/IJPP_147_2022 10.1016/S2221-1691(12)60449-3 10.3390/LIFE11090986 10.1016/J.YRTPH.2019.104404 10.3329/BJP.V11I3.27663 10.1007/978-1-62703-002-1_7 10.3389/fmed.2020.542567 10.1016/J.JEP.2013.02.003 10.1161/HYP.0000000000000066 10.3389/fphar.2022.812716 10.22270/jddt.v14i6.6570 10.1016/J.PHRS.2022.106531 10.1016/j.indcrop.2021.113278 10.1371/JOURNAL.PONE.0018413 10.1016/j.bjbas.2016.12.003 10.1787/9789264071001-EN 10.1371/JOURNAL.PONE.0284993 10.1016/J.JEP.2021.114048 10.1002/DDR.21935 10.1021/tx500403t 10.1006/abio.1976.9999 10.1007/978-0-387-70638-2 10.1016/J.JEP.2023.116206 10.1042/BSR20150076 10.3389/fphar.2015.00323 10.5344/ajev.1965.16.3.144 10.1021/acsmedchemlett.0c00126 10.1258/002367793781082368 10.1155/2013/627375 10.17762/jaz.v44iS6.2158 10.1161/CIRCULATIONAHA.107.748236 10.1016/J.EJPHAR.2011.12.040 10.1002/mco2.651 10.4103/aam.aam_6_17 10.1007/s10787-023-01219-8 10.3389/fphar.2023.1307799 10.1016/j.bjp.2016.01.005 10.3390/separations9090234 10.1016/J.FOODCHEM.2008.04.071 10.1016/0378-8741(87)90041-9 10.1016/j.coph.2019.04.014 10.1155/2014/291271 10.1016/j.crphar.2022.100139 10.3390/nu9101069 10.1016/J.JEP.2016.10.008 10.4103/0257-7941.107361 10.1016/j.biopha.2018.01.107 10.1016/j.jep.2015.09.031 10.1074/JBC.M710269200 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. Copyright Springer Nature B.V. Jun 2025 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. – notice: Copyright Springer Nature B.V. Jun 2025 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7TM 7U9 8FD C1K FR3 H94 K9. P64 RC3 7X8 |
| DOI | 10.1007/s12013-024-01594-1 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Genetics Abstracts Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Virology and AIDS Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1559-0283 |
| EndPage | 1877 |
| ExternalDocumentID | 39476265 10_1007_s12013_024_01594_1 |
| Genre | Journal Article |
| GroupedDBID | --- -Y2 -~X .86 .GJ .VR 06C 06D 0R~ 0VX 0VY 1N0 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 4.4 406 408 40D 40E 53G 5GY 5VS 67N 6NX 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHPBZ AHSBF AHWEU AIAKS AIGIU AIIXL AILAN AITGF AIXLP AIZAD AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN B-. BA0 BBNVY BDATZ BENPR BGNMA BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 H13 HCIFZ HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR IXC I~X I~Z J-C J0Z JBSCW JZLTJ KOV LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV ROL RPX RSV S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR ZMTXR ZOVNA ~A9 ~EX ~KM AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7TM 7U9 8FD C1K FR3 H94 K9. P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c326t-87c56f7dba430ff5677a5664f70bf3e949bc25a81efa788f4197ce1d0d51dc953 |
| IEDL.DBID | AGYKE |
| ISSN | 1559-0283 1085-9195 |
| IngestDate | Fri Sep 05 10:25:38 EDT 2025 Fri Jul 25 09:44:18 EDT 2025 Mon Jul 21 05:50:19 EDT 2025 Wed Oct 01 06:04:32 EDT 2025 Mon Jul 21 06:05:59 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Hypertension Vasorelaxant Arborside C Preclinical Nitric oxide Nyctanthes arbor-tristis |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-87c56f7dba430ff5677a5664f70bf3e949bc25a81efa788f4197ce1d0d51dc953 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2639-7096 |
| PMID | 39476265 |
| PQID | 3206242373 |
| PQPubID | 55397 |
| PageCount | 17 |
| ParticipantIDs | proquest_miscellaneous_3122635499 proquest_journals_3206242373 pubmed_primary_39476265 crossref_primary_10_1007_s12013_024_01594_1 springer_journals_10_1007_s12013_024_01594_1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-06-01 |
| PublicationDateYYYYMMDD | 2025-06-01 |
| PublicationDate_xml | – month: 06 year: 2025 text: 2025-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York – name: United States – name: Totowa |
| PublicationTitle | Cell biochemistry and biophysics |
| PublicationTitleAbbrev | Cell Biochem Biophys |
| PublicationTitleAlternate | Cell Biochem Biophys |
| PublicationYear | 2025 |
| Publisher | Springer US Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer Nature B.V |
| References | 1594_CR35 D Maaliki (1594_CR45) 2019; 45 S-Y Pan (1594_CR4) 2013; 2013 1594_CR36 B Bozin (1594_CR20) 2008; 111 1594_CR39 L Safaeian (1594_CR30) 2018; 100 OE Adebiyi (1594_CR18) 2017; 6 B Timsina (1594_CR49) 2016; 43 M Khanapur (1594_CR47) 2014; 2014 JJ Kim (1594_CR50) 2011; 6 S Patel (1594_CR38) 2022; 83 PB Nagendrappa (1594_CR5) 2013; 146 AA Syed (1594_CR34) 2016; 193 PK Whelton (1594_CR42) 2018; 71 1594_CR33 M Ajanal (1594_CR15) 2012; 31 1594_CR46 YH Du (1594_CR53) 2008; 117 VL Singleton (1594_CR16) 1965; 16 I Bello (1594_CR25) 2015; 175 PY Chia (1594_CR52) 2020; 7 KS Akki (1594_CR31) 2023; 44 M Ahmad (1594_CR40) 2022; 3 JP Yadav (1594_CR8) 2006; 5 NA Rahim (1594_CR48) 2022; 9 1594_CR1 S Manna (1594_CR10) 2016; 4 1594_CR3 T Jain (1594_CR32) 2024; 14 A Leitolis (1594_CR26) 2016; 26 1594_CR7 1594_CR41 1594_CR43 1594_CR12 K Verma (1594_CR24) 2023; 31 1594_CR56 1594_CR14 M Vijayalakshmi (1594_CR19) 2016; 11 1594_CR58 J-F Xu (1594_CR27) 2022; 13 1594_CR51 T Silambarasan (1594_CR54) 2012; 679 A Olowofela (1594_CR2) 2017; 16 M Mohan (1594_CR11) 2022; 66 E Gur (1594_CR55) 1993; 27 MM Bradford (1594_CR37) 1976; 72 1594_CR23 S Kesar (1594_CR28) 2020; 11 JA Edgar (1594_CR44) 2015; 28 A Arvouet-Grand (1594_CR17) 1994; 49 1594_CR29 SK Sen (1594_CR9) 2020; 8 RS Saxena (1594_CR6) 1987; 19 RK Saha (1594_CR13) 2012; 2 P Joshi (1594_CR22) 2021; 162 1594_CR21 IG Sharina (1594_CR57) 2008; 283 |
| References_xml | – volume: 66 start-page: 257 year: 2022 ident: 1594_CR11 publication-title: Indian Journal of Physiology and Pharmacology doi: 10.25259/IJPP_147_2022 – volume: 2 start-page: S1534 issue: 3 year: 2012 ident: 1594_CR13 publication-title: Asian Pacific Journal of Tropical Biomedicine doi: 10.1016/S2221-1691(12)60449-3 – ident: 1594_CR12 – volume: 43 start-page: 100 issue: 1 year: 2016 ident: 1594_CR49 publication-title: Chiang Mai Journal of Science – ident: 1594_CR56 doi: 10.3390/LIFE11090986 – ident: 1594_CR36 doi: 10.1016/J.YRTPH.2019.104404 – volume: 11 start-page: 570 issue: 3 year: 2016 ident: 1594_CR19 publication-title: Bangladesh Journal of Pharmacology doi: 10.3329/BJP.V11I3.27663 – ident: 1594_CR39 doi: 10.1007/978-1-62703-002-1_7 – volume: 7 year: 2020 ident: 1594_CR52 publication-title: Frontiers in Medicine doi: 10.3389/fmed.2020.542567 – volume: 146 start-page: 768 issue: 3 year: 2013 ident: 1594_CR5 publication-title: Journal of Ethnopharmacology doi: 10.1016/J.JEP.2013.02.003 – volume: 71 start-page: 1269 issue: 6 year: 2018 ident: 1594_CR42 publication-title: Hypertension (Dallas, Tex.: 1979) doi: 10.1161/HYP.0000000000000066 – volume: 13 year: 2022 ident: 1594_CR27 publication-title: Frontiers in Pharmacology doi: 10.3389/fphar.2022.812716 – volume: 14 start-page: 74 issue: 6 year: 2024 ident: 1594_CR32 publication-title: Journal of Drug Delivery and Therapeutics doi: 10.22270/jddt.v14i6.6570 – ident: 1594_CR35 doi: 10.1016/J.PHRS.2022.106531 – volume: 162 year: 2021 ident: 1594_CR22 publication-title: Industrial Crops and Products doi: 10.1016/j.indcrop.2021.113278 – volume: 6 start-page: e18413 issue: 4 year: 2011 ident: 1594_CR50 publication-title: PLOS ONE doi: 10.1371/JOURNAL.PONE.0018413 – volume: 6 start-page: 10 issue: 1 year: 2017 ident: 1594_CR18 publication-title: Beni-Suef University Journal of Basic and Applied Sciences doi: 10.1016/j.bjbas.2016.12.003 – ident: 1594_CR29 doi: 10.1787/9789264071001-EN – ident: 1594_CR51 doi: 10.1371/JOURNAL.PONE.0284993 – ident: 1594_CR23 doi: 10.1016/J.JEP.2021.114048 – volume: 83 start-page: 1097 issue: 5 year: 2022 ident: 1594_CR38 publication-title: Drug Development Research doi: 10.1002/DDR.21935 – volume: 28 start-page: 4 issue: 1 year: 2015 ident: 1594_CR44 publication-title: Chemical Research in Toxicology doi: 10.1021/tx500403t – volume: 72 start-page: 248 year: 1976 ident: 1594_CR37 publication-title: Analytical Biochemistry doi: 10.1006/abio.1976.9999 – ident: 1594_CR7 doi: 10.1007/978-0-387-70638-2 – ident: 1594_CR21 doi: 10.1016/J.JEP.2023.116206 – ident: 1594_CR58 doi: 10.1042/BSR20150076 – ident: 1594_CR3 doi: 10.3389/fphar.2015.00323 – volume: 16 start-page: 144 issue: 3 year: 1965 ident: 1594_CR16 publication-title: American Journal of Enology and Viticulture doi: 10.5344/ajev.1965.16.3.144 – volume: 11 start-page: 1694 issue: 9 year: 2020 ident: 1594_CR28 publication-title: ACS Medicinal Chemistry Letters doi: 10.1021/acsmedchemlett.0c00126 – volume: 27 start-page: 65 issue: 1 year: 1993 ident: 1594_CR55 publication-title: Laboratory Animals doi: 10.1258/002367793781082368 – volume: 2013 start-page: 1 year: 2013 ident: 1594_CR4 publication-title: Evidence-Based Complementary and Alternative Medicine doi: 10.1155/2013/627375 – ident: 1594_CR14 – volume: 44 start-page: 369 issue: S6 year: 2023 ident: 1594_CR31 publication-title: Journal of Advanced Zoology doi: 10.17762/jaz.v44iS6.2158 – volume: 117 start-page: 1045 issue: 8 year: 2008 ident: 1594_CR53 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.748236 – volume: 679 start-page: 81 issue: 1–3 year: 2012 ident: 1594_CR54 publication-title: European Journal of Pharmacology doi: 10.1016/J.EJPHAR.2011.12.040 – volume: 8 start-page: 22 issue: 2 year: 2020 ident: 1594_CR9 publication-title: International Journal of Herbal Medicine – ident: 1594_CR41 doi: 10.1002/mco2.651 – volume: 16 start-page: 114 issue: 3 year: 2017 ident: 1594_CR2 publication-title: Annals of African Medicine doi: 10.4103/aam.aam_6_17 – volume: 31 start-page: 1279 issue: 3 year: 2023 ident: 1594_CR24 publication-title: Inflammopharmacology doi: 10.1007/s10787-023-01219-8 – ident: 1594_CR33 doi: 10.3389/fphar.2023.1307799 – ident: 1594_CR43 – ident: 1594_CR1 – volume: 26 start-page: 363 issue: 3 year: 2016 ident: 1594_CR26 publication-title: Revista Brasileira de Farmacognosia doi: 10.1016/j.bjp.2016.01.005 – volume: 5 start-page: 323 issue: 3 year: 2006 ident: 1594_CR8 publication-title: Indian Journal of Traditional Knowledge – volume: 9 start-page: 234 issue: 9 year: 2022 ident: 1594_CR48 publication-title: Separations doi: 10.3390/separations9090234 – volume: 111 start-page: 925 issue: 4 year: 2008 ident: 1594_CR20 publication-title: Food Chemistry doi: 10.1016/J.FOODCHEM.2008.04.071 – volume: 19 start-page: 193 issue: 2 year: 1987 ident: 1594_CR6 publication-title: Journal of Ethnopharmacology doi: 10.1016/0378-8741(87)90041-9 – volume: 45 start-page: 57 year: 2019 ident: 1594_CR45 publication-title: Current Opinion in Pharmacology doi: 10.1016/j.coph.2019.04.014 – volume: 4 start-page: 81 year: 2016 ident: 1594_CR10 publication-title: Journal of Medicinal Plants Studies – volume: 2014 start-page: 1 year: 2014 ident: 1594_CR47 publication-title: BioMed Research International doi: 10.1155/2014/291271 – volume: 3 year: 2022 ident: 1594_CR40 publication-title: Current Research in Pharmacology and Drug Discovery doi: 10.1016/j.crphar.2022.100139 – ident: 1594_CR46 doi: 10.3390/nu9101069 – volume: 193 start-page: 555 year: 2016 ident: 1594_CR34 publication-title: Journal of Ethnopharmacology doi: 10.1016/J.JEP.2016.10.008 – volume: 31 start-page: 198 issue: 4 year: 2012 ident: 1594_CR15 publication-title: Ancient Science of Life doi: 10.4103/0257-7941.107361 – volume: 100 start-page: 147 year: 2018 ident: 1594_CR30 publication-title: Biomedicine & Pharmacotherapy doi: 10.1016/j.biopha.2018.01.107 – volume: 175 start-page: 422 year: 2015 ident: 1594_CR25 publication-title: Journal of Ethnopharmacology doi: 10.1016/j.jep.2015.09.031 – volume: 49 start-page: 462 issue: 6 year: 1994 ident: 1594_CR17 publication-title: Journal de Pharmacie de Belgique – volume: 283 start-page: 15104 issue: 22 year: 2008 ident: 1594_CR57 publication-title: The Journal of Biological Chemistry doi: 10.1074/JBC.M710269200 |
| SSID | ssj0022044 |
| Score | 2.4145885 |
| Snippet | Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs.
Nyctanthes arbor-tristis... Systemic hypertension, a common metabolic disorder, poses significant health risks despite the availability of antihypertensive drugs. Nyctanthes arbor-tristis... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1861 |
| SubjectTerms | Affinity Aluminum Aluminum chloride Animal models Animals Antihypertensive Agents - chemistry Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Antihypertensives Antioxidants Antioxidants - chemistry Antioxidants - pharmacology Aorta Assaying Betulinic acid Bioactive compounds Biochemical markers Biochemistry Biological and Medical Physics Biomedical and Life Sciences Biophysics Biotechnology Blood pressure Blood Pressure - drug effects Cell Biology Cyclic GMP Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Flavonoids Gene expression Guanylate cyclase Health risks Hydrogen peroxide Hypertension Hypertension - chemically induced Hypertension - drug therapy In vivo methods and tests Life Sciences Male Metabolic disorders Molecular docking Molecular Docking Simulation Nitric oxide Nitric Oxide Synthase Type III - chemistry Nitric Oxide Synthase Type III - metabolism Nyctanthes arbor-tristis Original Paper Parasympathetic nervous system Pharmacology/Toxicology Phenolic compounds Phytochemicals Plant Extracts - chemistry Plant Extracts - pharmacology Plant Extracts - therapeutic use Plant Leaves - chemistry Plant Leaves - metabolism Rats Rats, Wistar Spectrometry |
| Title | Nyctanthes arbor-tristis Improves Blood Pressure via Endothelial Pathway: In Silico, Ex Vivo, and In Vivo Evidence |
| URI | https://link.springer.com/article/10.1007/s12013-024-01594-1 https://www.ncbi.nlm.nih.gov/pubmed/39476265 https://www.proquest.com/docview/3206242373 https://www.proquest.com/docview/3122635499 |
| Volume | 83 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1559-0283 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022044 issn: 1559-0283 databaseCode: AFBBN dateStart: 19971001 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1559-0283 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022044 issn: 1559-0283 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1559-0283 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0022044 issn: 1559-0283 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB7BokpcWqAtTXnISNwgKImdh7ktaHkKhES3oqdonNhiVRSq3Szt8usZ57EroBy4JY7jOJ7P4xl7HgDbqInxJj66yuexK1SkXZWI3OWJsWHvYulpuw95cRmd9MXZTXjTOIWNWmv39kiy4tQzZ7egykQQWKuJUAqXdJ6F0CooHVjoHv86700VrcATonGQ-f-bzxehV5Llq1PRarE5-gT9tpu1jcnvvXGp9rLHFxEc3_sfS_CxkT5Zt4bLMszpYgU-1PkoJ59heDnJbFbhWz1iOCR0uGXFA0as3nug4gNr6M5qp8KhZg8DZL0it25cd4RkdkUC5V-c7LPTgl0P7ghmu6z3j_0cPNAFFrkttzeszWb6BfpHvR-HJ26TlMHNSNIriXtmYWTiXKHgnjFEzhhJJBQm9pThWgqpsiDExNcGSb02wpdxpv3cy0M_z2TIv0KnuC_0N2BItRPMuDDSExgJ5SnUhA0ReBFKVA7stFRK_9SxN9JZlGU7iimNYlqNYuo7sN4SMm3m4Sjl1JSVGGPuwNb0Mc0geyyChb4fUx0_sBF5SPVzYLUGwPRzXApaLaLQgd2WmLPG3-7L9_dVX4PFwKYVrjZ31qFTDsd6g2SdUm020N6E-X7QfQJDDPXr |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB6hRai9UOiLtLR1pd5KUBw7D3ODamEpsKpUtqKnaJzY6qooVLtZYPvrGeexq5b2wC1xHMfxjMff2PMA-ICGBG_K0ddcJL7UsfF1KgtfpNaFvUtUYNw-5NkwHozk54voonUKm3bW7t2RZC2pl85uYZ2JIHRWE5GSPuk8q5KnqezB6v7R95P-QtEKAylbB5l_v_nnInQPWd47Fa0Xm8MnMOq62diY_NydVXo3__1XBMeH_scGrLfok-037LIJK6Z8CmtNPsr5M5gM57nLKvzDTBlOiDv8qpYBU9bsPVDxgTN0Z41T4cSw6zGyflk4N65L4mT2hQDlDc732HHJvo4vic12WP-WfRtf0wWWhSt3N6zLZvocRof9808Dv03K4OeE9CqSnnkU26TQKEVgLZEzQYKE0iaBtsIoqXQeRphyY5HUayu5SnLDi6CIeJGrSLyAXnlVmi1gSLVTzIW0KpAYSx1oNMQbMgxiVKg9-NhRKfvVxN7IllGW3ShmNIpZPYoZ92C7I2TWzsNpJqgphxgT4cH7xWOaQe5YBEtzNaM6PHQReUj18-BlwwCLzwklabWIIw92OmIuG_9_X149rPo7eDQ4PzvNTo-HJ6_hcehSDNcbPdvQqyYz84ZwT6Xftmx-BzMw9_M |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZT-MwEB4hEIgXxLVsOI3EG0QksXOYN45WsAsVEnTFWzRObG0lFFAbjv57xknTgoAH3hJn4kQzY_sbew6APdQ08SY-usrnsStUpF2ViNzlibFp72LpabsPedWJzrviz1149y6Kv_J2b44k65gGm6WpKA8fc3M4CXwLqqoEgfWgCKVwyf6ZEbRWW_OrGxyPTa7AE2IUKvP1ex-Xo08Y89P5aLXstBdhYYQX2XEt4CWY0sUyzNYVJIcr0O8MM1sH-L8eMOyTPN2yGrUDVu8WUPOJdU1ndRhgX7PnHrJWkdvAq3vSPXZNEPAFh0fsomA3vXtSjAPWemX_es90gUVu2-0Na-qPrkK33bo9PXdHZRTcjLBZSfNdFkYmzhUK7hlDAoiRQJwwsacM11JIlQUhJr42SAaxEb6MM-3nXh76eSZD_gumi4dC_waGRJ1gxoWRnsBIKE-hJmmKwItQonJgv-Fm-lhny0gneZEt71PifVrxPvUd2GwYno5GziDl1JXFeDF3YHf8mHTeHmRgoR-eiMYPbA4dMtYcWKsFNf4cl4Lm9yh04KCR3KTz7_9l_WfkOzB3fdZOLy86fzdgPrA1gaudmU2YLvtPeouASqm2K118A85d30Y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nyctanthes+arbor-tristis+Improves+Blood+Pressure+via+Endothelial+Pathway%3A+In+Silico%2C+Ex+Vivo%2C+and+In+Vivo+Evidence&rft.jtitle=Cell+biochemistry+and+biophysics&rft.au=Chaturvedi%2C+Akanksha&rft.au=Verma%2C+Kanika&rft.au=Jain%2C+Smita&rft.au=Sharma%2C+Pragya&rft.date=2025-06-01&rft.issn=1559-0283&rft.eissn=1559-0283&rft.volume=83&rft.issue=2&rft.spage=1861&rft.epage=1877&rft_id=info:doi/10.1007%2Fs12013-024-01594-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12013_024_01594_1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-0283&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-0283&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-0283&client=summon |